Pricing Log in Create free account
Saturday 17 October 2026 Export COO’s income statement to Excel — free account

The Cooper Companies, Inc.

COO Healthcare Medical Instruments & Supplies

The Cooper Companies, Inc.’s revenue for fiscal 2025 (year ended October 2025) was $4.1 billion, up 5.06% from fiscal 2024. In the quarter to July 2026, revenue was flat, EPS grew 357.1%, free cash flow grew 66.0% and total debt rose 2.66%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five; insiders bought in the last twelve months.

57.94 0.54 +0.94%
Market cap
$10.9B
P/E
19.8×
Fwd P/E
28.7×
Dividend yield
—
F-score
5/9
Altman Z
3.48
Beneish M
−2.50
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

The Cooper Companies, Inc. 10-Q filed Sep 9, 2026

Fiscal Q3 2026 · Period ended Jul 31, 2026 · Filed · accepted 4:48 PM ET · Document on sec.gov · Filing index

What changed

Part I, Item 2, Management’s Discussion and Analysis Part II, Item 1A, Risk Factors
Previous quarter Same quarter last year

Part I, Item 2, Management’s Discussion and Analysis, against the 10-Q filed Jun 5, 2026: 16 added · 4 removed · 24 modified; 10 with only figures updated

  1. Added · CooperVision Net Sales by Category

    In the three months ended July 31, 2026, net sales across all categories were negatively impacted by unfavorable foreign exchange rate fluctuations of approximately $2.8 million, while in the three months ended July 31, 2025, net sales across all categories were positively impacted by favorable foreign exchange rate fluctuations of approximately $26.8 million.

43 more changes in this Item, word by word, in Powerpack.

Powerpack